In an interview with CNBC, Regeneron Pharmaceuticals (REGN +4.1%) CEO Leonard Schleifer said that
the company should have its coronavirus treatment ready for human
testing by August. It expects to be producing 200K prophylactic doses by
then.
Over the next few weeks, company scientists will screen a range of antibodies to identify the best ones to block the virus.
He also said that it is “committed” to an affordable product for patients.
https://seekingalpha.com/news/3548591-regeneron-expects-coronavirus-med-to-be-ready-august-shares-up-4
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.